Statin treatment in hypercholesterolemic men does not attenuate angiotensin II-induced venoconstriction. - Wikidata - awgldk - TriplyDB

Statin treatment in hypercholesterolemic men does not attenuate angiotensin II-induced venoconstriction.

Statin treatment in hypercholesterolemic men does not attenuate angiotensin II-induced venoconstriction.

http://www.wikidata.org/entity/Q35284008

about

Angiotensin-(1-7): new perspectives in atherosclerosis treatment Data quality of a wearable vital signs monitor in the pre-hospital and emergency departments for enhancing prediction of needs for life-saving interventions in trauma patients.

P2860

Q26770846-CAD7CAFE-BCA6-40F5-8C65-4C9DAABA1470 Q30974790-DAD8A54C-6722-4C4E-BBE6-2493AF1C02A0

P2860

Statin treatment in hypercholesterolemic men does not attenuate angiotensin II-induced venoconstriction.

http://www.wikidata.org/entity/Q35284008

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Statin treatment in hyperchole ...... n II-induced venoconstriction.

@ast

Statin treatment in hyperchole ...... n II-induced venoconstriction.

@en

type

label

Statin treatment in hyperchole ...... n II-induced venoconstriction.

@ast

Statin treatment in hyperchole ...... n II-induced venoconstriction.

@en

prefLabel

Statin treatment in hyperchole ...... n II-induced venoconstriction.

@ast

Statin treatment in hyperchole ...... n II-induced venoconstriction.

@en

P1433

Q35284008-FF9A59C1-4F12-47ED-88E8-0B12FF802135

P1476

Q35284008-FEFB57CC-5FBA-42DC-894C-96AD6BA96CAF

P2093

Q35284008-4093E56D-B1AB-4929-A9C4-D3DE0AB9C354

Q35284008-51BB71F1-C56C-43B6-9C36-510DC1038521

Q35284008-71C9F1C1-4A89-41E3-A2EF-23BF2AC7156A

Q35284008-89DB4444-3EDE-468E-AB64-D8F038D99F2A

Q35284008-902C81AA-1010-47E3-B955-681A2F20B38D

Q35284008-F05A9B58-2F74-4597-9BBE-83E2E6EBC1D8

Q35284008-F508A0B2-D498-4CC8-978D-4022FE531DC7

P2860

Q35284008-0768AAEB-F628-44FB-8187-DA80E3911DB2

Q35284008-157FA9EF-1C7B-4F16-BF22-E78CA6EF0C51

Q35284008-22E82A25-4EF2-4B08-865B-15A1428A0FB5

Q35284008-2AC347FE-BFC6-4624-8633-E74D8DA5A66D

Q35284008-2EF35842-8E2B-462E-968F-3F5F7F519892

Q35284008-30B6C37D-A210-4684-BA3B-F69B916EC979

Q35284008-329B64E8-FC0C-480C-852C-91DDCB736EAB

Q35284008-372A9D56-E7C1-40CF-9C1E-0DFA9E605EA3

Q35284008-39BBC49B-185D-489C-85B6-BCA19EA1494E

Q35284008-40E2CA95-FAA9-4602-AFEE-B74C95A85034

P304

Q35284008-4A499FEF-A582-40AE-8D9C-F8C40F6B6CEB

P31

Q35284008-B02E1C4D-EF5C-475A-A3C5-CC31C1C162DF

P356

Q35284008-F8E0CDCE-3F60-418E-BC62-84F92358B156

P407

Q35284008-22E869C3-F9C9-40FF-BBBD-98C3E7982BDA

P433

Q35284008-EF2E1873-4D02-4DCF-B84A-67D11EA2B185

P478

Q35284008-E19B0DDC-89B2-47A5-89C7-3E15F04CAF9C

P50

Q35284008-C67BDAD6-2956-42DA-8837-4EAE65DA8A7C

P577

Q35284008-064A2726-372C-4A13-B8A3-EBE63A0D2B3C

P5875

Q35284008-92A5AF3D-E22B-47D9-9FA0-1F74E17121C3

P698

Q35284008-EADDB5C7-18A1-4BA1-B1F1-892A20EBCC00

P921

Q35284008-76272600-B980-4B09-8F0C-A063995E0036

P932

Q35284008-5D0AA33C-23E8-4326-9938-ADD599A2F5B6

P356

JOURNAL.PONE.0103909

P1433

P1476

Statin treatment in hyperchole ...... n II-induced venoconstriction.

@en

P2093

Carlos M Ferrario

http://www.w3.org/2001/XMLSchema#string

Christoph Schroeder

http://www.w3.org/2001/XMLSchema#string

Cosima Hermann

http://www.w3.org/2001/XMLSchema#string

Jens Jordan

http://www.w3.org/2001/XMLSchema#string

Kristina Guenther

http://www.w3.org/2001/XMLSchema#string

Sven Haufe

http://www.w3.org/2001/XMLSchema#string

Wilhelm Kirch

http://www.w3.org/2001/XMLSchema#string

P2860

Cyclic guanosine monophosphate as a mediator of vasodilation

Heterogeneity in hand veins responses to acetylcholine is not associated with polymorphisms in the G-protein beta3-subunit (C825T) and endothelial nitric oxide synthase (G894T) genes but with serum low density lipoprotein cholesterol

Inhibition of geranylgeranylation reduces angiotensin II-mediated free radical production in vascular smooth muscle cells: involvement of angiotensin AT1 receptor expression and Rac1 GTPase.

Autonomic control of the venous system in health and disease: effects of drugs.

Angiotensin AT1 receptor over-expression in hypercholesterolaemia.

Angiotensin-converting enzyme 2 attenuates atherosclerotic lesions by targeting vascular cells

Angiotensin-(1-7) and low-dose angiotensin II infusion reverse salt-induced endothelial dysfunction via different mechanisms in rat middle cerebral arteries.

Modulating angiotensin II-induced inflammation by HMG Co-A reductase inhibition.

Interaction of endothelial nitric oxide and angiotensin in the circulation.

Hypercholesterolaemia exacerbates ventricular remodelling after myocardial infarction in the rat: role of angiotensin II type 1 receptors

P304

e103909

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0103909

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Christoph Schindler

P577

2014-09-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

266264622

http://www.w3.org/2001/XMLSchema#string

P698

25264877

http://www.w3.org/2001/XMLSchema#string

P921

hypercholesterolemia

P932

4179232

http://www.w3.org/2001/XMLSchema#string